Reed Thomas D. 4
4 · INTREXON CORP · Filed Jan 6, 2020
Insider Transaction Report
Form 4
Reed Thomas D.
DirectorChief Science Officer
Transactions
- Exercise/Conversion
Common Stock
2020-01-02+9,766→ 138,350 total - Exercise/Conversion
Restricted Stock Units
2020-01-02−9,766→ 19,531 total→ Common Stock (9,766 underlying) - Sale
Common Stock
2020-01-03$5.77/sh−2,986$17,229→ 135,364 total
Holdings
- 62,840(indirect: By Trust)
Common Stock
- 2,440(indirect: By Spouse)
Common Stock
- 41,705(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]Each restricted stock unit represents a contingent right to receive one share of XON common stock.
- [F2]This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units.
- [F3]Held by the Thomas David Reed Living Trust dated February 4, 2011.
- [F4]Held by the Jacquelyn Ann Reed Living Trust dated February 4, 2011.
- [F5]The restricted stock units were granted on January 2, 2018, and the remaining restricted stock units vest in two equal annual installments on each of January 2, 2021 and 2022.